Trial Profile
How does fish oil supplementation protect against atrial fibrillation following coronary artery by-pass surgery? - A cellular study.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2020
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 24 May 2020 Status changed from recruiting to discontinued.
- 27 Jul 2011 New trial record